Most Popular
Sponsored
Embree Financial buys $13.1M in CORO ETF, up 43% YTD. Active rotation strategy, 0.55% fee.
MU's 540% rally faces a growth slowdown risk; P/E < 9 suggests cheapness, but 2028 revenue dip looms.
Home Depot's flat comps & tepid outlook weigh on its 22% 3-yr return. Buy low for 2.7% yield?
Bayer's $63B Monsanto buy faces 100k+ Roundup cancer suits. SCOTUS to rule on preemption.
RNST eyes earnings after strong revenue beats. Peers show mixed results, but regional banks rally 8.1%. RNST up 11.2%.
IMAX CEO sells $2.8M shares; stock up 56% YTD, P/E 21. Buy on growth?
Strategy's Bitcoin holdings gain $1.8B on paper; STRC dividend fuels buys, but share dilution is a risk.
Sponsored
Must Read